Tel Aviv VC fund aMoon gets $250M from Credit Suisse, emerges as top player in Israel
Swiss multinational investment bank Credit Suisse is infusing $250 million into an Israeli life sciences VC firm, bringing the fund’s total to over $400 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.